| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Blackrock Health Sciences Term Trust (BMEZ) has 1 insider with recent SEC Form 4 filings, including 13 buys and 0 sells. BMEZ is classified in the Capital Markets industry within the Financials sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 31, 2023 | Saba Capital Management, L.P.67 | 10% Owner | Buy | 133,497 | $13.04 | $1,741,146.87 | +0.6% | +18.3% | +18.6% | |
| Oct 27, 2023 | Saba Capital Management, L.P.67 | 10% Owner | Buy | 231,587 | $13.26 | $3,071,327.51 | +1.0% | +14.4% | +17.2% | |
| Oct 25, 2023 | Saba Capital Management, L.P.67 | 10% Owner | Buy | 377,399 | $13.41 | $5,059,812.60 | +1.7% | +13.1% | +16.3% | |
| Mar 17, 2023 | Accettella Christopher55 | Portfolio Manager | Buy | 333 | $15.25 | $5,078.25 | +14.5% | +6.0% | +5.5% | |
| Mar 8, 2023 | Accettella Christopher55 | Portfolio Manager | Buy | 316 | $15.87 | $5,014.92 | +15.9% | +2.1% | +3.6% | |
| Feb 4, 2022 | Accettella Christopher55 | Portfolio Manager | Buy | 1,800 | $21.86 | $39,348.00 | New | -19.2% | -14.1% | |
| Dec 21, 2020 | Egan Cynthia | Director | Buy | 1,987 | $29.30 | $58,219.10 | New | - | - | |
| Mar 18, 2020 | McClements Kyle47 | Portfolio Manager | Buy | 1,700 | $13.58 | $23,086.00 | New | - | - | |
| Feb 24, 2020 | Cavanagh Richard | Director | Buy | 500 | $20.80 | $10,400.00 | New | - | - | |
| Feb 18, 2020 | Robards Karen P | Director | Buy | 50 | $21.30 | $1,064.85 | New | - | - |